Literature DB >> 10810312

Vascular endothelial growth factor in the rat pituitary: differential distribution and regulation by estrogen.

A L Ochoa1, N A Mitchner, C D Paynter, R E Morris, N Ben-Jonathan.   

Abstract

UNLABELLED: Vascular endothelial growth factor (VEGF), an endothelial cell mitogen and permeability factor, participates in tumor angiogenesis, but less is known about its regulation or function in normal vascular homeostasis. In the uterus, which undergoes cyclic changes in its vasculature, VEGF is induced by estrogen. Since the pituitary gland contains highly permeable capillaries and is estrogen-responsive, our objectives were to localize VEGF expression within the pituitary and to determine whether it is regulated by estrogen in both the pituitary and the somatolactotrope cell line, GH(3). Ovariectomized rats were injected with estradiol, and pituitaries and uteri were subjected to in situ hybridization or quantitative reverse transcription-polymerase chain reaction (RT-PCR). VEGF expression was strong and punctate in the neural lobe, weaker and diffuse in the anterior lobe and undetectable in the intermediate lobe. Two VEGF isoforms, 164 and 120, were detected in all tissues. In the posterior pituitary, VEGF expression was 3- to 6-fold higher than in the anterior pituitary or uterus and was unaltered by estrogen. In contrast, anterior pituitary VEGF was induced by estrogen within 1 h, peaked at 3 h, and returned to basal levels by 24 h. Similar dynamics, albeit 10-fold higher, were seen in the uterus. Translated VEGF proteins were detected by Western blot in both the anterior pituitary and uterus. GH(3) cells also showed a dose- and time-dependent induction of VEGF expression by estrogen. IN
CONCLUSION: (1) VEGF expression is higher in the neural lobe than in the anterior lobe and is undetectable in the intermediate lobe, (2) the expression of VEGF164 and VEGF120 is rapidly upregulated by estrogen in the anterior pituitary but is unchanged in the posterior pituitary, and (3) the pituitary lactotrope cell line, GH(3), also increases VEGF expression in response to estradiol.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10810312     DOI: 10.1677/joe.0.1650483

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  17 in total

1.  Modulation of VEGF/Flk-1 receptor expression in the rat pituitary GH3 cell line by growth factors.

Authors:  Matilde Lombardero; Sergio Vidal; Robert Hurta; Alba Román; Kalman Kovacs; Ricardo V Lloyd; Bernd W Scheithauer
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 2.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

3.  Subcellular localisation of VEGF in different pituitary cells. Changes of its expression in oestrogen induced prolactinomas.

Authors:  Jorge Humberto Mukdsi; Ana Lucía De Paul; Silvina Gutiérrez; Félix Daniel Roth; Agustín Aoki; Alicia Inés Torres
Journal:  J Mol Histol       Date:  2006-05-19       Impact factor: 2.611

4.  Angiopoietins are expressed in the normal rat pituitary gland.

Authors:  Sukriti Nag; Nima Nourhaghighi; Roopa Venugopalan; Sylvia L Asa; Duncan J Stewart
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

5.  Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice.

Authors:  Anna Lasorella; Gerson Rothschild; Yoshifumi Yokota; Robert G Russell; Antonio Iavarone
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

6.  Methoxychlor-induced alterations in the histological expression of angiogenic factors in pituitary and uterus.

Authors:  Jerome M Goldman; Ashley S Murr; Angela R Buckalew; Judith E Schmid; Barbara D Abbott
Journal:  J Mol Histol       Date:  2004-05       Impact factor: 2.611

7.  Differential expression of VEGF-A mRNA by 17beta-estradiol in breast tumor cells lacking classical ER-alpha may be mediated through a variant form of ER-alpha.

Authors:  Krishanu Sengupta; Snigdha Banerjee; Neela K Saxena; Nira Ben Jonathan; Donald R Campbell; Sushanta K Banerjee
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

8.  Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion.

Authors:  Teresa Gagliano; Carlo Filieri; Mariella Minoia; Mattia Buratto; Federico Tagliati; Maria Rosaria Ambrosio; Marcello Lapparelli; Matteo Zoli; Giorgio Frank; Ettore degli Uberti; Maria Chiara Zatelli
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

9.  Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.

Authors:  Katsuhiro Miyajima; Susumu Takekoshi; Johbu Itoh; Kochi Kakimoto; Takashi Miyakoshi; Robert Yoshiyuki Osamura
Journal:  Acta Histochem Cytochem       Date:  2010-04-07       Impact factor: 1.938

10.  Effect of estrogen on the blood supply of pituitary autografts in rats.

Authors:  Matilde Lombardero; Andres Quintanar-Stephano; Sergio Vidal; Eva Horvath; Kalman Kovacs; Ricardo V Lloyd; Bernd W Scheithauer
Journal:  J Anat       Date:  2009-02       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.